Sorry, We Can’t Find That PageThe link you clicked may be broken or this page has been removed (Error Code: 404).SuggestionsBusiness & Policy“Rapid Consolidation” in Oncology: New DataAaron TallentNews3 Min ReadNew data show that medical oncologist consolidation rose from 2015 to 2022. “The rate of consolidation seems to be rapid when compared to prior data,” said one author. Business & Policy“Rapid Consolidation” in Oncology: New DataAaron TallentNews3 Min ReadNew data show that medical oncologist consolidation rose from 2015 to 2022. “The rate of consolidation seems to be rapid when compared to prior data,” said one author. Endometrial and Uterine CancersNegative Trial May Inform Tx in Endometrial CancerLeah LawrenceNews3 Min ReadLenvatinib plus pembrolizumab did not meet primary endpoints in a phase 3 trial, but some prespecified subgroups may benefit from the combination. Endometrial and Uterine CancersNegative Trial May Inform Tx in Endometrial CancerLeah LawrenceNews3 Min ReadLenvatinib plus pembrolizumab did not meet primary endpoints in a phase 3 trial, but some prespecified subgroups may benefit from the combination. Business & PolicyMatch Day 2024 Results: One Specialty Sets RecordAlexis PellekNews4 Min ReadNational Residency Matching Program shares top medical specialties filled for Class of 2024. Plus, which field rebounded, where primary care offers stand, and the graduate group taking the most spots. Business & PolicyMatch Day 2024 Results: One Specialty Sets RecordAlexis PellekNews4 Min ReadNational Residency Matching Program shares top medical specialties filled for Class of 2024. Plus, which field rebounded, where primary care offers stand, and the graduate group taking the most spots. Antineoplastics/ChemotherapyFDA Updates Safety Label for Fluorouracil Youssef RddadNews2 Min ReadThe FDA updated safety labeling for fluorouracil injection products. The changes pertain to patients with dihydropyrimidine dehydrogenase deficiency. Antineoplastics/ChemotherapyFDA Updates Safety Label for Fluorouracil Youssef RddadNews2 Min ReadThe FDA updated safety labeling for fluorouracil injection products. The changes pertain to patients with dihydropyrimidine dehydrogenase deficiency. Multiple MyelomaODAC Votes on Two CAR-T Therapies in MyelomaYoussef RddadNews4 Min ReadMost ODAC members affirmed that the benefits of two CAR T-cell therapies outweigh potential early death risks in relapsed or refractory multiple myeloma. Multiple MyelomaODAC Votes on Two CAR-T Therapies in MyelomaYoussef RddadNews4 Min ReadMost ODAC members affirmed that the benefits of two CAR T-cell therapies outweigh potential early death risks in relapsed or refractory multiple myeloma. Business & PolicyFDA Cancer Drug Withdrawal Illustrates ConcernsNeil OsterweilNews5 Min ReadThe recent withdrawal a cancer drug that had been granted accelerated approval by the FDA may be illustrative of concerns raised by some critics. Business & PolicyFDA Cancer Drug Withdrawal Illustrates ConcernsNeil OsterweilNews5 Min ReadThe recent withdrawal a cancer drug that had been granted accelerated approval by the FDA may be illustrative of concerns raised by some critics. Endometrial and Uterine Cancers“Unprecedented” OS Gain Seen in Endometrial CancerLeah LawrenceNews3 Min Read“This is something that…should be incorporated into everyone’s practice yesterday,” one expert said. Endometrial and Uterine Cancers“Unprecedented” OS Gain Seen in Endometrial CancerLeah LawrenceNews3 Min Read“This is something that…should be incorporated into everyone’s practice yesterday,” one expert said. Chronic Lymphocytic Leukemia (CLL)FDA Approves First-Ever CAR-T Therapy in CLL, SLLMarcia FrellickNews3 Min ReadThe FDA approved lisocabtagene maraleucel for use in adult patients with relapsed or refractory CLL or SLL, the first CAR-T therapy to receive such approval. Chronic Lymphocytic Leukemia (CLL)FDA Approves First-Ever CAR-T Therapy in CLL, SLLMarcia FrellickNews3 Min ReadThe FDA approved lisocabtagene maraleucel for use in adult patients with relapsed or refractory CLL or SLL, the first CAR-T therapy to receive such approval. Business & PolicyPBM Reform Update: Major Changes Coming Soon?Aaron TallentNews3 Min ReadThe window for PBM reform this year is small; however, lawmakers are increasingly engaged on the issue, and major changes may arrive soon, experts say. Business & PolicyPBM Reform Update: Major Changes Coming Soon?Aaron TallentNews3 Min ReadThe window for PBM reform this year is small; however, lawmakers are increasingly engaged on the issue, and major changes may arrive soon, experts say. Business & PolicyPBM Reform Update: Major Changes Coming Soon?Aaron TallentNews3 Min ReadThe window for PBM reform this year is small; however, lawmakers are increasingly engaged on the issue, and major changes may arrive soon, experts say. Business & PolicyPBM Reform Update: Major Changes Coming Soon?Aaron TallentNews3 Min ReadThe window for PBM reform this year is small; however, lawmakers are increasingly engaged on the issue, and major changes may arrive soon, experts say. Lung CancerMore Immunotherapy AEs, Better Survival in NSCLC?Youssef RddadNews4 Min ReadImmune-related adverse events from immunotherapy for advanced NSCLC was tied to better survival, regardless of severity, although the link remains “contentious.” Lung CancerMore Immunotherapy AEs, Better Survival in NSCLC?Youssef RddadNews4 Min ReadImmune-related adverse events from immunotherapy for advanced NSCLC was tied to better survival, regardless of severity, although the link remains “contentious.” Urothelial CarcinomaFrom “Fairytale” to Reality in Bladder Cancer?Robert Dreicer, MD, Robert A. Figlin, MD, FACPPodcastRobert Dreicer, MD, and Robert A. Figlin, MD, discuss “paradigm-shifting” data in bladder cancer that mean optimistic outcomes are “not as much of a fairytale.” Urothelial CarcinomaFrom “Fairytale” to Reality in Bladder Cancer?Robert Dreicer, MD, Robert A. Figlin, MD, FACPPodcastRobert Dreicer, MD, and Robert A. Figlin, MD, discuss “paradigm-shifting” data in bladder cancer that mean optimistic outcomes are “not as much of a fairytale.” Load More